This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
People with pockets of fat hidden inside their muscles are at a higher risk of dying or being hospitalized from a heart attack or heartfailure, regardless of their body mass index, according to new research. This is the first study to comprehensively investigate the effects of fatty muscles on heartdisease.
The existing oral and intravenous forms of bumetanide are commonly prescribed for people with heartfailure because they ease tissue swelling, a common cause of symptoms for people with heartfailure.
In adults with congenital heartdisease (ACHD patients), atrial arrhythmias (AA) and heartfailure (HF) are common. 1 Factors related to congenital heartdisease, such as underlying anatomy, surgical repair technique and scars, can all be considered as AA substrates.
Statement Highlights: Previous studies have found that 14-81% of patients with heartfailure experience some degree of cognitive impairment affecting language, memory or executive function. Evidence also indicates that people with atrial fibrillation.
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heartdisease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
Background Atrial arrhythmias (AA) and heartfailure (HF) are major causes of hospitalisation in adult congenital heartdisease (ACHD). Methods In this single-centre retrospective cohort study, data from 3995 patients with ACHD were analysed.
Heartfailure (HF) is a complex syndrome which leads to significant morbidity and mortality, poor quality of life and extremely high costs to healthcare systems worldwide. In this review, we aim to comprehensively describe the burden of HF from an LMIC perspective, based on the more recent available data.
Three common cardiovascular diseases in adults—heartfailure, atrial fibrillation and coronary heartdisease—are linked to cognitive impairment and increased risk of dementia, according to "Cardiac Contributions to Brain Health," a new scientific statement from the American Heart Association published today in the journal, Stroke.
In mice, this protein was able to restore the heart by activating dormant repair genes without causing side effects, such as heart enlargement. This study marks an important step toward regenerative therapies to prevent heartfailure.
Protein aggregates are emerging therapeutic targets in rare monogenic causes of cardiomyopathy and amyloid heartdisease, but their role in more prevalent heart-failure syndromes remains mechanistically unexamined.
A new small study has revealed the impact of obesity on muscle structure in patients having a form of heartfailure called heartfailure with a preserved ejection fraction (HFpEF).
Finerenone reduced the composite of total first and recurrent heartfailure (HF) events (hospitalizations for HF or urgent HF visits) and cardiovascular death in patients with HF and mildly reduced or preserved ejection fraction, according to an international clinical trial.
Researchers have reduced scar formation and improved heart function in mouse models of heartfailure using a monoclonal antibody treatment, similar to that approved by the FDA to treat other conditions.
A new American Heart Association scientific statement suggests addressing cardiovascular health earlier in life may reduce the risk of stroke and help preserve thinking and memory later in life.
A novel study co-authored by a heartfailure cardiologist demonstrates the effectiveness of a newly developed scoring system in identifying patients with HeartFailure with Preserved Ejection Fraction (HFpEF).
Coronary heartdisease (CHD), with common complications including myocardial infarction, arrhythmia, heartfailure, is one of the leading causes of global death. Both elevated lactate levels and decreased albumin levels may reflect the body's stress response and inflammatory reaction.
Heartfailure during pregnancy is a dangerous and often under-detected condition because common symptoms -- shortness of breath, extreme fatigue and trouble breathing while lying down -- are easily mistaken for typical pregnancy discomforts.
For adults with congenital heartdisease (ACHD), those with heartfailure (HF) hospitalizations have an increased risk for mortality and morbidity, according to a study published in the Dec. 5 issue of the Journal of the American Heart Association.
Scientists discovered that blocking the activity of the hormone glucagon could treat a common and challenging type of heartfailure that affects millions worldwide.
Care for survivors after an acute attack of COVID-19 should include paying close attention to cardiovascular health and disease.Systematic Review RegistrationPROSPERO [CRD42022353965].
Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heartfailure for patients with obesity and heartfailure with preserved pump function, new research reveals.
A critical review of cell-based and cell product-based therapies for the treatment of heartfailure details 20 years of completed and ongoing clinical trials. While none has yet gained medical approval, pathways to new treatments for heartfailure can take decades, as seen for two other, now accepted therapies.
Pre-eclampsia and heartfailure have common risk factors, including hypertension, obesity and diabetes. It is not known whether heartfailure increases the risk of pre-eclampsia. This study examines whether pregestational heartfailure increases the risk of pre-eclampsia.
A mouse study of heartfailure with preserved ejection fraction (HFpEF) found male-female differences at the cellular level. The findings could have implications for how HFpEF is treated in women compared to men.
In ambulatory women ages 63-99 years, higher amounts of usual daily light and moderate intensity activities were associated with lower risk of developing heartfailure with preserved ejection fraction independent of demographic and clinical factors associated with heartfailure risk.
FDA granted CardiAMP Cell Therapy a Breakthrough Device Designation for the treatment of ischemic heartfailure. Leslie Miller, MD , trial investigator at the CHF Heart Function Clinic at BayCare Morton Plant Hospital in Clearwater, Florida and a member of the CardiAMP HeartFailure II Study Executive Steering Committee. “As
An analysis based on a proposed heartfailure risk prediction tool reveals that the incidence of heartfailure may be 2- to 3-fold higher among American Indian adults compared to people in other population groups.
announced that the peer-reviewed Journal of the American College of Cardiology: HeartFailure has published a research paper concluding that INPEFA (sotagliflozin) is cost-effective for people with diabetes and recent worsening heartfailure using commonly accepted willingness-to-pay thresholds. “Our healthcare system.
A recent study utilized a machine learning-based approach to identify, understand, and predict diuretic responsiveness in patients with acute decompensated heartfailure (ADHF).
In a new study, researchers show that elevated levels of proteins related to cellular senescence, or aging, in the blood and the placenta are linked to this form of heartfailure.
healthcare providers can now detect Low EF, a key heartfailure indicator, in 15 seconds using an Eko stethoscope during a routine physical examination. This leap in early detection marks both a significant medical innovation and a new era in the detection of cardiovascular disease. Heartfailure. In the U.S.,
Henry Ford Health's Center for Structural HeartDisease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heartfailure patient on February 13, 2024 at Henry Ford Hospital in Detroit. She is only the third patient in the U.S. to receive the device.
Patients who have been treated for heartfailure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heartfailure medications.
” This is one of the most common questions I get as a cardiologist when talking about preventing heartdisease and living longer. And there are so many things a person can do to prevent heartdisease and live longer. Death from heartdisease: 51% reduction in risk. HeartFailure: 69% reduction in risk.
Researchers have found a potential method to slow heartfailure progression. They fed mice a diet high in soybean protein, which influenced gut bacteria and supported heart health. Analysis showed that this diet increased the production of the short-chain fatty acids in the gut that help to protect the heart.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content